Two on-going scientific studies, recently reported in The Times, are suggesting that Type 1 diabetes and some forms of cancer may be treatable in the future.
Type 1 Diabetes
Research currently being undertaken by Cardiff University in conjunction with King’s College London, has shown that not only is peptide immunotherapy safe to use on patients with type 1 diabetes but that it may also improve their ability to produce their own insulin.
Type 1 diabetes, which affects approximately 400,000 people in the UK is caused by an immune system dysfunction which allows insulin-producing cells to be destroyed. Researchers are trying to target those areas of the immune system which cause diabetes without reducing the effectiveness of the immune system overall to protect the patient against disease.
Cancer Research
In an altogether different field, researchers at the Institute of Cancer Research, with colleagues from the Royal Marsden NHS Foundation Trust have been working with international colleagues to assess the efficacy of a targeted cancer drug.
The results have shown that some patients with advanced and aggressive forms of cancer of the gut and stomach have survived for ten years and beyond with the drug Imatinib. This suggests that other gene-targeted forms of chemotherapy may offer solutions to a wider range of cancers in the future.
Substandard Medical Care
If you have been the victim of poor quality medical care, you may be able to make a claim for compensation.
Glynns Solicitors is a specialist medical negligence legal practice, offering a team of skilled and experienced solicitors. We would be happy to discuss your experience with you and advise you as to the best way forward.
Please call us on 0800 234 3300 (or from a mobile 01275 334030) or complete our Online Enquiry Form.
Share Article With:
|
|
|
|
|
|
